Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1% Market Closed
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
EPS (Diluted) Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
EPS (Diluted)
€0
CAGR 3-Years
45%
CAGR 5-Years
43%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
EPS (Diluted)
-$2
CAGR 3-Years
5%
CAGR 5-Years
16%
CAGR 10-Years
11%
Galapagos NV
AEX:GLPG
EPS (Diluted)
€5
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
EPS (Diluted)
-€114
CAGR 3-Years
-445%
CAGR 5-Years
-158%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's EPS (Diluted)?
EPS (Diluted)
-0.2 EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's EPS (Diluted) amounts to -0.2 EUR.

What is Celyad Oncology SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
43%

Over the last year, the EPS (Diluted) growth was 87%. The average annual EPS (Diluted) growth rates for Celyad Oncology SA have been 45% over the past three years , 43% over the past five years .

Back to Top